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Abstract Carbohydrate-deficient transferrin (CDT) has been
established as a valuable biological marker for detecting chronic
alcohol abuse. To improve the diagnostic efficiency, we studied
new CDT determination procedures involving the use of lectin
affinity chromatography with Allomyrina dichotoma agglutinin
(allo A) and Trichosanthes japonica agglutinin I (TJA-I) to
isolate the CDT isoforms CDT-allo A and CDT-TJA, respec-
tively. These procedures, based on detection of the CDT-allo A
and CDT-TJA isoforms in sera, showed high sensitivity (100%
and 98%, respectively) and high specificity (93% and 85%,
respectively). These results demonstrate that the new procedures
involving the use of lectin affinity chromatography are more
useful for isolating markers in the CDT test than the
conventional charge-based separation method.
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1. Introduction
Many types of plasma proteins are glycosylated with N-
linked oligosaccharides. Human transferrin has two potential
glycosylation sites which are normally occupied by N-linked
oligosaccharide chains. However, as evidence of its microhe-
terogeneity, carbohydrate-de¢cient transferrin (CDT) is ob-
served in patients with chronic alcohol abuse (CAA) and
the isoforms present are disialo- and asialo-transferrin with
isoelectric points of 5.7 and 5.9, respectively [1]. These CDT
isoforms were found to lack one or both of the N-linked
oligosaccharide chains entirely [2,3]. The same transferrin ab-
normality was found in patients with an autosomal recessive
disease with multiple organ manifestations, carbohydrate-de-
¢cient glycoprotein syndrome type 1A (CDGS 1A) [4,5].
CDT has been established as a valuable biological marker
for detecting individuals with CAA. Several methods based on
isocratic anion exchange chromatography followed by immu-
noassays have been developed for its measurement [1,6]. How-
ever, recent studies have shown false-positive CDT test results
for individuals with one of several non-alcoholic liver diseases
causing hyposialylation by fucosylation [7^11] and some ge-
netic variants causing a shift of isoelectric point [1,12], be-
cause the separation of the CDT fraction from non-speci¢c
isoforms is insu⁄cient by charge-based separation procedures,
owing to the close isoelectric points [6,13]. Unfortunately,
because patients with CAA often su¡er from liver diseases,
their abnormal transferrin isoforms consist of hyposialylated
transferrins and deglycosylated transferrins.
To improve the diagnostic e⁄ciency for clinical purposes,
we studied CDT determination procedures involving the use
of lectin a⁄nity chromatography with Allomyrina dichotoma
agglutinin (allo A) [14,15] and Trichosanthes japonica aggluti-
nin I (TJA-I) [16]. Although both lectins interact fundamen-
tally with sialic acid (Sia)K2C6 galactose (Gal)L1C4 N-ace-
tylglucosamine (GlcNAc) residues in N-linked oligosaccha-
rides, we recently found that not only non-glycosylated trans-
ferrin but also a disialylated transferrin isoform passes
through an allo A-Sepharose column using two disialylated
transferrins derived from a CDGS 1A patient (Ohkura and
Yamashita, unpublished results), and the allo A-Sepharose
column is more useful to determine CAA transferrin than
the TJA-I-Sepharose column and charge-based separation
procedures.
2. Materials and methods
2.1. Patients and controls
The subjects of the present study included three patients with
CDGS 1A, 41 patients with alcohol-related disorders, 20 patients
with hepatocellular carcinoma (HCC) and 20 healthy controls. These
84 subjects all had the TF C phenotype (TF C1, 59.5%; TF C2-1,
33.3%; TF C2, 7.2%). In addition, a healthy individual with another
genetic variant, TF C1-Dsaga [17], was examined. Serum samples
were collected from each of the three patients with CDGS 1A; these
patients have been described in previous papers [4,5,18,19]. They were
diagnosed as having CDGS 1A based on distinctive clinical features
[18] and the occurrence of multiple carbohydrate-de¢cient glycopro-
teins [19]. Forty-one serum samples were obtained from patients with
a well-documented history of continual alcohol consumption. All of
them ful¢lled the DSM IV criteria (American Psychiatric Association,
1994) for alcohol-related disorders. In each case, the level of ethanol
consumption was estimated to be more than 120 g/day during the
2 weeks prior to admission based on personal interviews. Blood was
drawn at the time of admission. The 20 patients with HCC had under-
lying non-alcoholic liver cirrhosis (all of them were HCVAb-positive)
as determined by ultrasonography, computed tomography and histo-
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logical examination. These patients had no history of ethanol con-
sumption for a long time prior to blood sampling. The healthy con-
trols were 20 volunteers, either teetotalers or social drinkers, who
consumed 0^30 g ethanol/day on any occasion.
All serum samples were stored and carefully kept at 380‡C until
analysis. This study was carried out in accordance with the Declara-
tion of Helsinki. Informed consent to participate in the study was
obtained from each participant.
2.2. Determination of CDT-allo A and CDT-TJA values
CDT-allo A and CDT-TJA are CDT isoforms isolated by means of
an allo A-Sepharose column and a TJA-I-Sepharose column, respec-
tively. The value of each isoform in serum was expressed as a per-
centage of the total serum transferrin content.
Allo A-Sepharose (5 mg lectin/ml gel) and TJA-I-Sepharose (5 mg
lectin/ml gel) were prepared according to the methods described pre-
viously [16,20]. Each column (1.0 ml, 7.5 mm inner diameter) was
equilibrated with 50 mM Tris-HCl bu¡er, pH 7.4, containing 0.5 M
NaCl. After diluting the serum sample 1:10 with the above-mentioned
bu¡er, a 10 Wl aliquot was applied to the column, and it was left to
stand for 15 min. Then the column was irrigated with the same bu¡er.
The ¢rst 10 ml of eluate was collected as the CDT fraction. The
fraction and total transferrin content were measured by the method
described below.
2.3. Enzyme immunoassay of transferrin
The assay employed for quantitative determination of transferrin
levels was basically a double-antibody sandwich ELISA described
previously [21]. Incubations were carried out at room temperature.
Rabbit anti-human transferrin (Dako, Glostrup, Denmark) was di-
luted 5000-fold in 50 mM sodium carbonate, pH 9.6. A 200 Wl aliquot
was applied to each well of the microtiter plates (Sumitomo Bakelite,
Tokyo, Japan) and the plates were incubated for 1.5 h. The plates
were then rinsed three times with 10 mM phosphate bu¡er, pH 7.2,
containing 0.15 M NaCl and 0.05% Tween 20 (PBS-Tween), and
blocked with 300 Wl of 1% bovine serum albumin in 50 mM sodium
carbonate, pH 9.6, for 1 h. Each standard or sample was diluted with
PBS-Tween, and a 200 Wl aliquot was added in duplicate to the coated
wells. After incubation for 1 h, the plates were washed three times
with PBS-Tween. A 200 Wl aliquot of chicken anti-human transferrin
(Bethyl, Montgomery, TX, USA) diluted 5000-fold with PBS-Tween
was added to the plates, and the plates were incubated for 1 h. After
the plates were washed again, 200 Wl of rabbit anti-chicken/turkey IgG
(heavy+light chain) conjugated with horseradish peroxidase (Zymed,
South San Francisco, CA, USA) diluted 5000-fold with PBS-Tween
was added to each well, and the plates were incubated for 1 h. Then
the plates were washed again, and 200 Wl of substrate solution was
added to each well. The substrate solution, 13 mg of o-phenylenedi-
amine in 50 ml of 0.2 M phosphate bu¡er, pH 6.0, and 0.01% hydro-
gen peroxide, was prepared just before use. The plates were incubated
in the dark for 30 min. After stopping the reaction with 50 Wl of 1 M
sulfuric acid, the absorbance of the contents of each well at 490 nm
was determined by means of a microtiter plate reader (EIA plate
reader, model ELNX 96, TFB, Tokyo, Japan).
2.4. %CDT TIA
The CDT level in all serum samples was also analyzed by anion
exchange chromatography followed by a turbidimetric immunoassay
performed using a commercially available assay kit %CDT TIA (Axis
Biochemicals, Oslo, Norway).
2.5. Isoelectric focusing (IEF) and immunoprinting
IEF was performed according to the methods described previously
[18,22], using polyacrylamide gels in the pH range 5^7 (Ampholine,
Pharmacia, Uppsala, Sweden). Immunoprinting was carried out using
cellulose acetate strips (Separax, Fuji Film, Tokyo, Japan) soaked in
anti-human transferrin antibodies (Dako) diluted 1:3 with PBS. Each
damp-dried strip was placed on the surface of the gel for 3 min. After
washing in PBS for 1 h, the strip was stained with Coomassie brilliant
blue R-350 (Pharmacia).
2.6. Statistical analysis
All data are expressed as mean þ S.D. Means of four subgroups
were compared by one-way analysis of variance (ANOVA) for global
analysis. The signi¢cance of di¡erences between two subgroups was
analyzed by the Sche¡e¤ test. For correlation analysis, the Spearman
correlation coe⁄cient (r) was used. Probability values less than 0.05
were considered to be statistically signi¢cant. Sensitivity was de¢ned
as the proportion of the actively drinking patients and patients with
CDGS 1A who had a positive test, whereas speci¢city was the pro-
portion of healthy controls and patients with HCC who tested neg-
ative.
3. Results
3.1. Elution pro¢les obtained with lectin columns
In analysis of serum samples from the patients with CAA
and the healthy controls, after serum samples were applied to
both the allo A-Sepharose column and the TJA-I-Sepharose
column (Fig. 1), the absorbed and pass-through transferrins
were analyzed with IEF (Fig. 2). Pentasialo-, tetrasialo- and
trisialo-transferrin became adsorbed to both of these columns
and were eluted with lactose. Non-glycosylated (asialo-)trans-
ferrin did not bind to either of the columns (Fig. 2, lanes B
and D). Disialo-transferrin was found to bind to the TJA-I-
Sepharose column (Fig. 2, lane E), in contrast, a portion of
the total disialo-transferrin (about 50%) passed through the
allo A-Sepharose column (Fig. 2, lane B), the remaining dis-
ialo-transferrin was absorbed to the column (Fig. 2, lane C).
3.2. CDT-allo A value
The individual CDT values obtained for patients and
healthy controls are shown as dot plots in Fig. 3. For the
healthy controls, the mean serum CDT-allo A value was
0.8 þ 0.3%. The cut-o¡ point for a normal serum CDT-allo
A value was set at 1.4%, corresponding to 2 S.D. above the
mean of the healthy controls. In the patients with CDGS 1A
and those with CAA, the serum levels were elevated compared
to the control group and the mean CDT-allo A values were
18.1 þ 4.6% and 6.8 þ 4.0%, respectively. In the patients with
HCC, the serum levels were not elevated and the mean CDT-
Fig. 1. Elution pro¢les obtained in allo A-Sepharose and TJA-I-
Sepharose column chromatography of transferrin from a healthy
control (A, B) and a patient with CAA (C, D). A 10 Wl aliquot of
each diluted serum sample was applied to each column. Columns
were irrigated with a bu¡er solution consisting of 50 mM Tris-HCl,
pH 7.4, and 0.5 M NaCl and then with the same bu¡er containing
0.1 M lactose from the position indicated by the black arrow. The
column temperature was continuously maintained at room tempera-
ture. The eluted transferrin in each fraction was assayed by means
of an enzyme immunoassay as described in Section 2. P indicates
the elution position of bovine serum albumin.
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allo A value was 0.9 þ 0.4%. Signi¢cant di¡erences in CDT-
allo A values were detected comparing healthy controls and
patients with CDGS 1A (P6 0.0001), or comparing healthy
controls and patients with CAA (P6 0.0001), but no signi¢-
cant di¡erence was detected comparing healthy controls and
patients with HCC. The results obtained in the assay of CDT-
allo A showed CDT values below the cut-o¡ (1.4%) for 18 of
20 patients with HCC, and 19 of 20 healthy controls, whereas
positive results were obtained for all of the three patients with
CDGS 1A and for all of the 41 patients with CAA (Fig. 3,
top). The sensitivity and speci¢city within this population
were 100% (all of 44) and 93% (37 of 40), respectively.
3.3. CDT-TJA value
For healthy controls, the mean serum CDT-TJA value was
0.7 þ 0.3%. The cut-o¡ point for a normal serum CDT-TJA
value was set at 1.3% (mean+2 S.D.). The mean serum CDT-
TJA values for patients with CDGS 1A, those with CAA and
those with HCC were 9.2 þ 2.9%, 3.3 þ 2.1% and 0.9 þ 0.5%,
respectively. Signi¢cant di¡erences in CDT-TJA values were
detected comparing healthy controls and patients with CDGS
1A, or comparing healthy controls and patients with CAA
(P6 0.0001), but no signi¢cant di¡erence was detected com-
paring healthy controls and patients with HCC. The results
obtained in the assay of CDT-TJA showed CDT values below
the cut-o¡ (1.3%) for 15 of 20 patients with HCC, and 19 of
20 healthy controls, whereas CDT-positive values were ob-
tained for all three of the patients with CDGS 1A and 40
of 41 patients with CAA (Fig. 3, middle). The sensitivity
and speci¢city within this population were 98% (43 of 44)
and 85% (34 of 40), respectively.
3.4. Axis %CDT TIA value
The results obtained in terms of %CDT TIA for the same
subject populations were 21.4 þ 2.9 for the patients with
CDGS 1A, 12.2 þ 4.6 for those with CAA, 6.9 þ 1.6 for those
with HCC and 2.9 þ 0.8 for the healthy controls. The mean
serum %CDT TIA value for the patients with HCC was 2.4-
fold greater than that for the healthy controls. Signi¢cant
di¡erences in %CDT TIA values were detected comparing
healthy controls and patients with CDGS 1A (P6 0.0001),
comparing healthy controls and patients with CAA
(P6 0.0001) and comparing healthy controls and patients
with HCC (P6 0.005). %CDT TIA values below the cut-o¡
(6.0%, according to the manual provided by the manufac-
turer) were obtained for six of the 20 patients with HCC
and for all of the 20 healthy controls. False-positive results
Fig. 2. IEF patterns of serum transferrin from a patient with CAA,
as revealed by isoelectric focusing and immunoprinting. Arrows in-
dicate the numbers of sialic acid residues. Before separation by lec-
tin columns (lane A); CDT isoforms separated by allo A-Sepharose
(lane B); isoforms adsorbed to allo A-Sepharose (lane C); CDT iso-
forms separated by TJA-I-Sepharose (lane D); isoforms adsorbed to
TJA-I-Sepharose (lane E). The anode is at the top.
Fig. 3. Distribution of CDT-allo A (top), CDT-TJA (middle) and
%CDT TIA (bottom) values. Cont, healthy controls. A signi¢cant
di¡erence compared with the healthy controls is shown by asterisks:
**P6 0.0001; *P6 0.005; n.s. : not signi¢cant.
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were obtained for 14 (70%) of the 20 patients with HCC.
CDT-positive values were found for all three of the patients
with CDGS 1A and 38 of 41 patients with CAA (Fig. 3,
bottom). The sensitivity of the %CDT TIA method was
93% (41 of 44), while its speci¢city was 65% (26 of 40).
3.5. Correlation between CDT tests
A signi¢cant correlation was found between the CDT-allo
A and %CDT TIA values (y = 0.91x+6.00, r = 0.88,
P6 0.0001) (Fig. 4, left), between the CDT-TJA and %CDT
TIA values (y = 1.68x+6.70, r = 0.86, P6 0.0001) (Fig. 4, mid-
dle), and between the CDT-allo A and CDT-TJA values
(y = 1.81x+0.87, r = 0.96, P6 0.0001) (Fig. 4, right). The sim-
ilarity of the data obtained by the two lectin column proce-
dures re£ects their high correlation coe⁄cient. However, the
CDT-allo A values were signi¢cantly higher than the CDT-
TJA values for the patients with CAA and those with CDGS
1A.
3.6. CDT test results for the subject with TF D
In the case of the healthy individual with the TF C1-Dsaga
phenotype, the mean %CDT TIA value was extremely high
showing a false-positive result, while the CDT-allo A and
CDT-TJA values were below the cut-o¡ (Fig. 5).
4. Discussion
We have clearly demonstrated that underglycosylated trans-
ferrin can be detected using allo A-Sepharose and TJA-I-Se-
pharose, with high sensitivity (100% and 98%, respectively)
and high speci¢city (93% and 85%, respectively). On the other
hand, the %CDT TIA method showed fairly high sensitivity
(93%), but its speci¢city was considerably low (65%). Both
allo A and TJA-I strongly interact with oligosaccharides con-
taining SiaK2C6 GalL1C4 GlcNAc residues [15,16]. Because
normal transferrin (tetrasialo-transferrin) has two bi-anten-
nary glycans containing SiaK2C6 GalL1C4 GlcNAc residues
[23,24] and the CDT isoforms lack either one or both of the
N-linked glycans [2,3], it was predicted that non-glycosylated
transferrin would pass through either of these two lectin col-
umns, whereas a disialo-transferrin which has a bi-antennary
sugar chain possessing SiaK2C GalL1C4 GlcNAc residues
[2^5] would be absorbed to both columns. As the results dem-
onstrate, both CDT-allo A and CDT-TJA values are more
useful than %CDT TIA values for detecting patients with
CAA, and those with CDGS 1A. Moreover, false-positive
results are not obtained in the case of patients with severe
non-alcoholic liver disease such as HCC, because CDT-allo
A and CDT-TJA values re£ect the levels of partially or com-
pletely underglycosylated transferrin in the sera of patients
with CAA and those with CDGS 1A.
The correlation coe⁄cient between the CDT-allo A and
CDT-TJA values was the highest, and the CDT-allo A values
were signi¢cantly higher than the CDT-TJA values in spite of
the similarity in sugar speci¢cities of the two lectins. In the
sera of patients with CAA, not only non-glycosylated (asia-
lo-)transferrin but also monoglycosylated (disialo-)transferrin
levels are elevated. The former passed through both columns
and the latter became adsorbed to the TJA-I-Sepharose col-
umn. However, about 50% of the disialo-transferrin passed
through the allo A-Sepharose column. Considering that the
non-glycosylated asparagine site in disialo-transferrin has
been shown to be random in patients with CDGS 1A [5],
and that one of the isolated two disialo-transferrin isoforms
was absorbed to the allo A column and the other isoform
passed through the column by steric hindrance, the same phe-
nomenon seems to occur in the case of disialo-transferrin iso-
forms present in the sera of patients with CAA. From these
points of view, the CDT-allo A value is a more reliable
marker for detecting patients with chronic alcohol abuse
than the CDT-TJA value.
Fig. 4. Correlation between results for CDT tests; between %CDT TIA and CDT-allo A values (left), between %CDT TIA and CDT-TJA val-
ues (middle), between CDT-allo A and CDT-TJA values (right), for three patients with CDGS 1A (a) and 41 patients with CAA (b).
Fig. 5. Comparison of IEF band patterns and CDT values. Arrows
indicate the numbers of sialic acid residues in the case of TF C1
and TF Dsaga. A healthy control (lane A), a patient with CDGS
1A (lane B), a patient with CAA (lane C), a patient with HCC
(lane D) with TF C1 (lane A-D) and a healthy individual with the
genetic variant, TF C1-Dsaga (lane E). The anode is at the top.
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The occurrence of false-positive results in the %CDT TIA
test in the case of patients with severe non-alcoholic liver
dysfunction such as those with HCC has been previously re-
ported [11]. This is due to altered glycosylation of transferrin
in patients with HCC resulting in the occurrence of fucosy-
lated, asialyl, or highly branched N-linked oligosaccharides of
transferrin, responsible for its altered isoelectric point [25], but
importantly, underglycosylation does not occur in such cases.
Because the abnormal transferrin isoforms observed in cases
of HCC should interact with allo A-Sepharose and TJA-I-
Sepharose [15,16], the CDT test based on CDT-allo A and
CDT-TJA values should not give false-positive results in the
case of patients with HCC.
It has been reported that in the case of healthy individuals
with the genetic D variant, which occurs more frequently in
certain populations [26,27], false-positive results are obtained
in the CDT test [1,12]. The %CDT TIA value obtained for a
healthy individual with the TF C1-Dsaga phenotype showed a
false-positive result, because the D variant isoforms of trans-
ferrin have higher isoelectric points. On the other hand, CDT-
allo A and CDT-TJA values obtained for this individual with
TF Dsaga were below the cut-o¡, because the variants have
two N-linked glycans per protein molecule. These results in-
dicate that CDT-allo A and CDT-TJA values are not depend-
ent on the isoelectric points of transferrin isoforms, and that
the lectin column procedures employed here are more suitable
than charge-based separation methods for detecting CAA.
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